Publications

Publications

281 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

Indacaterol acetate/mometasone furoate (Atectura® Breezhaler®) for the maintenance treatment for asthma in adults and adolescents of 12 years and older

Zorginstituut Nederland has completed its assessment whether indacaterol acetate/mometasone furoate (Atectura® Breezhaler®) can ...

Report | 24-09-2020

Osimertinib (Tagrisso®) for the treatment of locally advanced or metastatic non-small cell lung carcinoma (NSCLC) with an epidermal growth factor receptor (EGFR) mutation (reassessment)

The Minister of Medical Care has requested Zorginstituut Nederland to reassess whether osimertinib (Tagrisso®) for the treatment ...

Report | 21-09-2020

Avelumab (Bavencio®) in combination with axitinib as a first-line treatment for adult patients with advanced renal cell carcinoma

Zorginstituut Nederland has completed its assessment whether avelumab (Bavencio®) in combination with axitinib can be included in ...

Report | 21-09-2020

Conditional inclusion procedure for medicinal products

This document describes the conditional inclusion procedure for orphan drugs, conditionals and exceptionals.

Publication | 30-07-2020

Ibrutinib (Imbruvica®) for the treatment of Waldenstrom's disease

Zorginstituut Nederland has completed its assessment whether ibrutinib (Imbruvica®) for the treatment of adult patients with ...

Report | 03-07-2020

Ibrutinib (Imbruvica®) for the treatment of adult patients with previously untreated chronic lymphatic leukaemia (CLL)

Zorginstituut Nederland has completed its assessment whether ibrutinib (Imbruvica®) for the treatment of adult patients with ...

Report | 03-07-2020

GVS assessment of Trifarotene (50 microgram/gram cream) (Aklief®) for the cutaneous treatment of acne vulgaris on the face and torso in patients aged 12 years and over

Zorginstituut Nederland has completed its assessment whether trifarotene (50 microgram/gram cream) (Aklief®) for the cutaneous ...

Report | 11-06-2020

International strategic agenda 2020 National Health Care Institute

When performing its tasks, the National Health Care Institute (Zorginstituut Nederland, or ZIN) participates with various other ...

Publication | 30-05-2020

Oral semaglutide (Rybelsus®) for the treatment of adults with insufficiently controlled type 2 diabetes mellitus

Zorginstituut Nederland has completed its assessment whether oral semaglutide (Rybelsus®) is interchangeable with a product that ...

Report | 29-05-2020

Pentosan polysulfate sodium (Elmiron®) for the treatment of bladder pain syndrome characterized by either glomerulations or Hunner’s lesions

Zorginstituut Nederland has completed its assessment whether pentosan polysulfate sodium (Elmiron®) is interchangeable with a ...

Report | 28-04-2020